Transdiagnostic Cognitive Biomarkers
Recruiting · NCT04864080 · Interventional (participants receive a specific treatment) · Lead sponsor: University of Minnesota
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
The overall objective of this study is to determine the feasibility of identifying transdiagnostic biomarkers of cognitive function mediated by neuromodulation of the dorsolateral prefrontal cortex that are translatable across disease groups in order to more accurately phenotype clusters of cognitive dysfunction. Completing behavioral paradigms with electrophysiology and TMS is a challenging frontier. This study focuses on the feasibility of such an endeavor for those with chronic pain or depression as well as healthy controls.
Who can take part
Inclusion criteria
- Have access to the online study platform.
Exclusion criteria
- under 18, non-English speaking
- Arm 2: pain and depression:
- Inclusion Criteria:
- Pain or depression
- Exclusion Criteria:
- pregnant women
Where it is running
1 location listed across 1 US state.
- University of Minnesota - Minneapolis, Minnesota, United States